Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer

Details for Australian Patent Application No. 2008302099 (hide)

Owner CGI Pharmaceuticals, Inc.

Inventors Schmitt, Aaron C.; Zhichkin, Pavel E.; Zhao, Zhongdong; Blomgren, Peter A.; Mitchell, Scott A.; Currie, Kevin S.; Xu, Jianjun; Kroft, Jeffrey E.; Stafford, Douglas G.; Lee, Seung H.

Agent Davies Collison Cave

Pub. Number AU-A-2008302099

PCT Pub. Number WO2009/039397

Priority 60/973,995 20.09.07 US; 61/050,777 06.05.08 US

Filing date 19 September 2008

Wipo publication date 26 March 2009

International Classifications

C07D 241/08 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/497 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/039397 Priority application(s): WO2009/039397

25 October 2012 Assignment before Grant

  CGI Pharmaceuticals, Inc. The application has been assigned to Gilead Connecticut, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008302105-Reverse link traffic power control

2008302092-Interference mitigation in a wireless communication system